Detalhe da pesquisa
1.
Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized Trials.
Circulation
; 149(8): 574-584, 2024 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870970
2.
Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registry.
Eur Heart J Cardiovasc Pharmacother
; 10(1): 11-19, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37742213
3.
Impact of Polyvascular Disease in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention.
Am J Cardiol
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697455
4.
Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary intervention.
J Cardiol
; 82(3): 179-185, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37187289
5.
Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS study.
Eur Heart J Acute Cardiovasc Care
; 12(9): 594-603, 2023 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37459570
6.
Outcomes After Complex PCI With COMBO Stent Implantation: Insights from a Real-World Pooled Dataset.
Am J Cardiol
; 209: 52-54, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37866281